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Objective: We found previously that interferon regulatory factor (Irf)-1 is a germinal vesicle (GV)-selective gene that highly expressed in GV as 
compared to metaphase II oocytes. To our knowledge, the function of Irf-1 in oocytes has yet to be examined. The present study was conduct-
ed to determine the relationship between retinoic acid (RA) and RA-mediated expression of Irf-1 and the mouse oocyte maturation. 
Methods: Immature cumulus-oocyte-complexes (COCs) were collected from 17-day-old female mice and cultured in vitro for 16 hours in the 
presence of varying concentrations of RA (0-10 µM). Rate of oocyte maturation and activation was measured. Gene expression was measured 
by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) and cytokine secretion in the medium was measured by Bio-
Plex analysis. Apoptosis was analyzed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. 
Results: The rates of oocyte maturation to metaphase II and oocyte activation increased significantly with RA treatment (10 nM-1 µM). With 
100 nM RA treatment, lowest level of Irf-1 mRNA and cumulus cell’s apoptosis was found. Among 23 cytokines measured by Bio-Plex system, 
the substantial changes in secretion of tumor necrosis factor-α, macrophage inflammatory protein-1β, eotaxin and interleukin-12 (p40) from 
COCs in response to RA were detected. 
Conclusion: We concluded that the maturation of oocytes and Irf-1 expression are negatively correlated, and RA enhances the developmental 
competence of mouse immature oocytes in vitro by suppressing apoptosis of cumulus cells. Using a mouse model, results of the present study 
provide insights into improved culture conditions for in vitro oocyte maturation and relevant cytokine production and secretion in assisted re-
productive technology. 
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Introduction 
Oocyte maturation is a progression of developmental programs 
that are essential for the production of an oocyte that is competent 
to undergo fertilization and embryogenesis [1]. There are three dif-
ferent components of oocyte maturation: nuclear, cytoplasmic and 
epigenetic maturation [2]. Nuclear maturation refers to the resump-
tion of meiosis and progression to metaphase II (MII) [3]. Cytoplasmic 
maturation includes all of the processes that occur in the cytoplasm, 
exclusive of meiotic changes in the nucleus, which prepare the oo-
cyte for fertilization and embryo development. Cytoplasmic matura-
tion occurs throughout oocyte growth and is concurrent with nuclear 
maturation [4]. Epigenetic maturation also occurs during oocyte grow-
th, and refers to sequence-independent modifications of DNA struc-
ture that regulate gene expression during oocyte development, oo-
cyte maturation and post-fertilization [5]. 
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Previously, in an effort to better understand the molecular mecha-
nisms involved in the acquisition of oocyte competence, we used an-
nealing control primer-polymerase chain reaction (PCR) to identify 
differentially expressed genes (DEGs) in the germinal vesicle (GV) 
and in MII mouse oocytes [6]. Among the DEGs that were identified, 
interferon regulatory factor (Irf)-1 emerged as a GV-selective gene 
that was highly expressed in GV as compared to MII oocytes. To our 
knowledge, the function of Irf-1 as it relates to the meiotic cell cycle 
and maturation in oocytes has yet to be examined. 
Extracellular growth factors that modify Irf-1 expression include com-
mon mediators of a variety of biologic processes, including cell cycle 
progression, DNA damage and apoptosis, cell differentiation, cell-to-
cell contact inhibition, and cell senescence. The involvement of Irf-1 
in cell cycle regulation and apoptosis has been studied extensively in 
cells and tissues, and its function as a tumor suppressor can be ex-
plained at least in part by its function at the mitotic checkpoint [7]. 
One of the well-known inducers of Irf-1 is retinoic acid (RA), one of 
the active forms of vitamin A. Vitamin A plays an essential role in ver-
tebrate physiology, in such processes as cellular growth, develop-
ment, differentiation, including oocyte maturation [8-11]. The active 
forms of vitamin A, namely all-trans-RA (atRA) and 9-cis-RA (9cRA), 
bind to their cognate ligand-activated transcription factors, RA re-
ceptor (Rar) and retinoid X receptor (Rxr), each of which exists as one 
of three isoforms (α, β, and γ). Retinoid signals are reached at the 
gene level by RAR-RXR heterodimers, which activate or repress spe-
cific target genes through binding to specific response elements 
near promoter regions [12]. The production and secretion of several 
cytokines, including interferon-γ (IFN-γ), tumor necrosis factor-α (TNF- 
α), interleukin (IL)-1, IL-2, IL-3, IL-4, and transforming growth factor-β 
(TGF-β), have been shown to be modulated by RA and RA metabo-
lites in neutrophils, natural killer cells, and T- and B-lymphocytes [13]. 
It has also been reported that vitamin A supplementation has a 
positive effect on bovine fertility using artificial reproductive meth-
ods, and it has been suggested that RA might promote cytoplasmic 
maturation of bovine oocytes through the modulation of gene ex-
pression in cumulus-granulosa cells [9]. Addition of 9cRA into the IVM 
medium of bovine cumulus-oocyte-complexes (COCs) increased rates 
of embryo development and hatching [14]. 
Since RA and the induction of Irf-1 by RA can establish or change 
the pattern of gene expression in various cells, we interested in whe-
ther these events also influenced the maturation and subsequent ca-
pacity of the mouse oocytes to progress through embryonic devel-
opment. In the current study, we investigated the effects of RA treat-
ment on immature COCs on the oocyte maturation, the expression 
of many cytokines and genes including Irf-1 and the cumulus cells’ 
apoptosis. 
Methods
1. Animals
ICR mice were housed in the breeding facility at the CHA Stem Cell 
Institute of CHA University (Seoul, Korea) in a temperature-controlled 
environment under a 12 hours light/12 hours dark cycle. Animals 
were fed ad libitum. All animal procedures were reviewed and ap-
proved by the University of Science Institutional Animal Care and Use 
Committee, and performed in accordance with the Guiding Princi-
ples for the Care and Use of Laboratory Animals.
2. Collection of mouse oocytes, IVM, and oocyte activation
Immature GV stage oocytes were obtained from 17-day-old ICR fe-
male mice 44 hours after the injection of 5 IU of pregnant mare se-
rum gonadotropin (PMSG; Folligon, Intervet, Boxmeer, Holland). COCs 
were collected in M2 medium (Sigma, Louis, MO, USA) containing 0.2 
mM 3-isobutyl-1-methyl-xanthine (IBMX; Sigma) to maintain the oo-
cytes at the GV stage. COCs were recovered from the ovaries by punc-
turing the surface of the ovary, and then cultured at 37°C in a 5% CO2 
incubator in M16 medium (Sigma) containing 3 mg/mL bovine se-
rum albumin (BSA; Sigma) and increasing concentrations (0 nM, 10 
nM, 100 nM, 1 µM, 10 µM) of RA, as indicated. The vehicle solution 
was 0.01% ethanol. After 16 hours in culture, oocytes were denuded 
and examined using a stereomicroscope to determine maturation 
stage. Emission of the first polar body was used as an indicator of pro-
gression to MII. Oocytes without GVs or polar bodies were scored as 
MI. Isolated oocytes, remnant cumulus cells and culture medium were 
snap-frozen and stored at -70°C. 
To determine cytoplasmic maturation status, oocytes were parthe-
nogenetically activated by incubation in activating medium (Ca
2+- 
free CZB supplemented with 10 mM SrCl2 [Sigma] containing 5 µg/
mL cytochalasin B [Sigma]) at 37°C in a humidified atmosphere of 5% 
CO2. 6 hours after the onset of activation, oocytes were examined by 
microscopy. 
3. RNA isolation and reverse transcription (RT)-PCR
Messenger RNA (mRNA) was isolated from the same number of oo-
cytes and cumulus cells (derived from the same COCs) using a Dyna-
beads mRNA Direct Kit (Dynal, Oslo, Norway), according to the man-
ufacturer’s instructions. Cells were resuspended in lysis/binding buf-
fer (containing lithium dodecylsulphate/lithium chloride) for 5 min-
utes at room temperature, and then the solution was incubated with 
Dynabeads oligo (dT)25 at room temperature for 5 minutes to sepa-
rate mRNA from total RNA. Bound mRNA was immobilized against 
the wall of a microfuge tube using a magnet (Dynal MPC-S; DYNAL 
A.S, Oslo, Norway), and the supernatant was removed. Dynabead/
mRNA complexes were washed twice with lysis buffer and then three www.eCERM.org
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times with washing buffer. The complexes were resuspended in 10 
µL of Tris-HCl (10 mM Tris-HCl, pH 7.5) at 65°C for 2 minutes, and then 
an aliquot was used for reverse transcription.
PCR was carried out in a reaction mixture consisting of 20 mM Tris-
HCl (pH 8.4), 50 mM KCl, 2.5 mM MgCl2, 0.2 mM dNTPs, 25 pmol of 
each primer, and 2.5 U of Taq DNA polymerase (Promega, Madison, 
WI, USA) in a final volume of 20 µL. Amplified products (20 µL) were 
separated by 1.2% agarose gel electrophoresis and assessed using 
an Image Analyzer (Viber Lourmat). The sequences of the gene-spe-
cific primers (β-Actin was used as an internal control), as well as the 
PCR conditions, are listed in Table 1. 
4. Quantitative real-time RT-PCR
Quantitative real-time RT-PCR analysis was also accomplished as 
described previously [15]. Quantitative real-time RT-PCR analysis was 
performed using an iCycler system (Bio-Rad, Hercules, CA, USA) and 
the results were evaluated using iCycler iQ real-time detection sys-
tem software. The template was amplified by 40 cycles of denatur-
ation at 95°C for 40 second, annealing at 60°C for 40 second, and ex-
tension at 72°C for 40 second. At the completion of the PCR, we moni-
tored fluorescence continuously while slowly heating the samples 
from 60°C to 95°C at 0.5°C intervals, producing melting curves to iden-
tify any nonspecific products. Gene amplification was quantified by 
determining the cycle threshold (CT), based on the level of fluores-
cence within the geometric region of the semilog amplification plot. 
The mRNA level of each target gene was calculated using the com-
parative CT method, and the experiments were repeated at least three 
times using different sets of oocytes and cumulus cells. 
5. Terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) assay
All COCs, including the control and treatment groups, were washed 
in PVP (1 mg/mL polyvinyl-pyrolidone in phosphate buffered saline) 
and then fixed in a solution of 3.7% paraformaldehyde (w/v) and 0.2% 
Triton X-100 for 40 minutes at room temperature. The fixed COCs 
were washed twice in PVP and then incubated in 0.5% Triton X-100 
for 1 hour at room temperature. The samples were then incubated 
for 1 hour at 37°C in TUNEL reaction mixture (In situ Cell Death Detec-
tion Kit, Roche, Mannheim, Germany). After the TUNEL reaction was 
completed, nuclei were stained with Hoechst 33342 (2 µg/mL) for 30 
minutes, and the COCs were mounted on slides using Vectashield 
mounting medium (Vector Laboratories Inc., Burlingame, CA, USA). 
Slides were observed by a laser-scanning confocal microscopy (LSM 
510, Carl Zeiss, Dublin, CA, USA). Simulated 3D images and sections 
were constructed using the software Volocity (PerkinElmer, Waltham, 
MA, USA). 
6. Bio-Plex analysis
Changes in the amounts of cytokines in culture media during IVM 
were measured using the Bio-Plex 2200 system (Bio-Rad). The Bio-
Plex filter plate was pre-wet with buffer prior to the addition of sam-
ples. Antibody-coupled beads for 23 different cytokines (IL-1a, IL1b, 
IL-2, IL-3, IL-4, IL-5,IL-6, IL-9, IL-10, IL-12 [p40], IL-12 [p70], IL-13, IL-17, 
G-CSF, GM-CSF, INF-γ, KC, macrophage inflammatory protein [MIP]-
1α, RANRES, TNF-α, eotaxin, MCP-1, and MIP-1β) were premixed (06-
0143; Bio-Rad), and assays were carried out according to the manu-
facturer’s protocol. After loading of the bead solutions and samples, 
the plate was incubated for 30 minutes at room temperature with 
shaking. After washing three times, detection antibodies were added 
and the plate was incubated for 30 minutes, followed by the addition 
of streptavidin-PE for 10 minutes. The plate was agitated to resuspend 
the beads, and the amount of cytokine was measured using the Bio-
Plex 2200 system. Each reaction was carried out in duplicate and the 
experiment was repeated three times. 
7. Statistical analysis
All statistical analyses were performed on a CHA University main-
frame computer using the Statistical Analysis System (SAS; SAS Korea 
Inc., Seoul, Korea), version Enterprise 4.0. At least three independent 
Table 1. Sequences of oligonucleotide primers, annealing tempera-
tures (AT) and expected reverse transcription-polymerase chain reac-
tion product sizes
Genes GeneBank 
accession No. Oligonucleotide sequences AT 
(°C)
Size 
(bp)
IRF-1 NM_008390 F 5’-CCCTGGCTAGAGATGCAGATTA-3’ 60 439
R 5’-TAGAGCTGCTGAGTCCATCAGA-3’
RARα NM_009024 F 5’-GCCTGAGCAAGACACAATGA-3’ 60 378
R 5’-CCTGGGATCTCCATCTTCAA-3’
RARβ NM_011243 F 5’-GGACCTTGAGGAACCAACAA-3’ 60 210
R 5’-ATGAGAGGTGGCATTGATCC-3’
RARγ NM_011243 F 5’-AAGCCCACCAGGAGACTTTT-3’ 60 242
R 5’-GATCCGCAGCATTAGGATGT-3’
RXRα NM_011305 F 5’-GCTCACCAAATGACCCTGT-3’ 60 320
R 5’-CGTCTTGTCCATCTGCATGT-3’
RXRβ NM_011306 F 5’-CTGCAAGGGTTTCTTCAAGC-3 60 280
R 5’-GGGGCTGAAGGAGGGAGG-3’
RXRγ NM_009107 F 5’-AATGCTCTTGGCTCTCCGTA-3’ 60 301
R 5’-AATGCTCTTGGCTCTCCGTA-3’
Fshr NM_013523 F 5’-AGAGGCTCCCTGVAAAACAT-3’ 60 165
R 5’-TCCTTCATGGGACTGAGCTT-3’
Gdf9 NM_008110 F 5’-GGTTCTATCTGATAGGCGAGG-3’ 60 472
R 5’-GGGGCTGAAGGAGGGAGG-3’
β-Actin NM_007393 F 5’-GGGTGTGATGGTGGGAATGGG-3’ 60 314
R 5’-GCTGTGGTGGTGAAGCTGTAG-3’
Gapdh BC093598 F 5’-ACCACAGTCCATGCCATCAC-3’ 60 512
R 5’-TCCACCACCCTGTTGCTGTA-3’  http://dx.doi.org/10.5653/cerm.2011.38.4.193
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experiments were conducted for each treatment condition. The rate 
of maturation, oocyte activation, the rate of apoptosis and cytokine 
levels were evaluated using a mixed model analysis of variance pro-
cedure (PROC MIXED; SAS) followed by Fisher’s least significant dif-
ference. Data are expressed as mean±SE, and a p-value of <0.05 was 
considered significant. 
Results
1. Characterization of Irf-1 and RAR expression
Expression of Irf-1 mRNA was analyzed by quantitative real-time PCR 
(Figure 1A). Irf-1 was highly expressed in GV oocytes as compared to 
MII oocytes. In each case of melting curve, there was a single peak 
that indicated the absence of nonspecific amplicons (inset, Figure. 
1A). Irf-1 mRNA was ubiquitously expressed in ovarian follicular cells 
(Figure 1B). 
Rarα and Rxrα mRNAs were expressed in both oocytes and cumulus 
cells. Rarγ and Rxrβ were highly expressed in cumulus cells as com-
pared to oocytes, while the expression of Rxrγ was not detected in 
oocytes or cumulus cells (Figure 1C). Growth differentiation factor 9 
(Gdf9) and FSH receptor (Fshr) expression was measured as an indica-
tor for clear cell separation between oocytes and granulosa cells. 
600
550
500
450
400
350
300
250
200
150
100
50
0
-50
600
550
500
450
400
350
300
250
200
150
100
50
0
-50
P
C
R
 
b
a
s
e
 
l
i
n
e
 
s
u
b
t
r
a
c
t
e
d
 
C
F
 
R
F
U
Cycles
0  2  4  6  8  10 12 14 16 18 20 22 24 26 28 30  32 34 36 38 40 42
1
0.8
0.6
0.4
0.2
0
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
 
l
e
v
e
l
 
(
f
o
l
d
)
GV MII
Irf-1
GV  CC
Rarα
Rarβ
Rarγ
Rxrα
Rxrβ
Rxrγ
Gdf9
Fshr
β-Actin
378 bp
210 bp
242 bp
320 bp
280 bp
301 bp
472 bp
165 bp
314 bp
GV  CC  GC
Irf-1 439 bp
472 bp
165 bp
512 bp
Gdf9
Fshr
Gapdh
A
B C
Figure 1. Levels of interferon regulatory factor (Irf)-1 and retinoic acid (RA) 
receptor mRNA. (A) Quantitative real-time reverse transcription-polymer-
ase chain reaction (RT-PCR) analysis of Irf-1 mRNA expression in germinal 
vesicle (GV) and metaphase II (MII) mouse oocytes. The cDNA equivalent 
of a single oocyte was used as the template for amplification. Left side, 
line graph shows the difference of CT values between GV and MII oocytes 
and right side, bar graph shows expression levels calculated using its CT 
value. (B) Analysis of Irf-1 mRNA level in mouse follicular cells using RT-PCR. (C) Levels of Rarα, Rarβ, Rarγ, Rxrα, Rxrβ, Rxrγ, Gdf9, Fshr, and β-Actin 
mRNA transcripts. Gdf9 mRNA was used as a specific marker for oocytes, and Fshr was used as a marker for cumulus and granulosa cells. GV, GV 
oocytes; CC, cumulus cells; GC, granulosa cells, Gdf9, growth differentiation factor; Fshr, follicle stimulating hormone receptor; Gapdh, glyderal-
dehyde 3-phosphate dehydrogenase; Rar, retinoic acid receptor; Rxr, retinoid X receptor.
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17 day-old ICR mouse
Cumulus-oocyte complexes (COCs)
• Cytokine analysis
Oocytes Cumulus cells Medium
• Maturation rate
• Gene expression
• Apoptosis analysis
PMSG 44 hours
RA treatment  
in vitro culture, 16 hours
Figure 2. Schematic diagram of the experimental strategy for evalu-
ating the effects of retinoic acid (RA) on the oocyte maturation in mo-
u se. Cumulus-oocyte-complexes (COCs) from preovulatory follicles 
were collected from the ovaries of 17 day-old mice 44 hours after 
PMSG injection. COCs were incubated with various doses (0-10 µM) 
of RA. At the end of culture period for 16 hours, the oocytes were de-
nuded and examined using a stereomicroscope to determine the 
progression of meiotic maturation. PMSG, pregnant mare se rum go-
nadotropin; Oocyte, cumulus cells, and conditioned medium were 
sampled and snap frozen for further analysis.
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Figure 3. The effect of retinoic acid (RA) treatment on the oocyte maturation in vitro. (A) The effect of RA on nuclear maturation. Mouse cumu-
lus-oocyte-complexes (COCs) obtained from 17-day-old mice were incubated with increasing doses of RA. The oocytes were then denuded, 
and examined using a stereomicroscope to score the progression of meiotic maturation. Emission of the first polar body was used as an indica-
tor of progression to metaphase II (MII). Oocytes without germinal vesicle (GV) or polar bodies were scored as metaphase I (MI). Data represents 
the means±SE of at least three experiments. Letter a, indicates that group means were significantly different from the control group. Letter b, 
indicates that the conditions, 10 nM, 100 nM, and 1 µM are significantly different from the control group for both MI and MII (p<0.001). (B) The 
effect of RA on cytoplasmic maturation. Activation of IVM mouse oocytes after treatment with RA was measured. Six hours after the onset of 
activation, oocytes were observed under a microscope. Oocytes with pronuclei, or two cells with each one nucleus, were considered activated. 
Data represents the mean±SE of at least three experiments. Letter c, indicates that group means were significantly different from the vehicle 
group (p<0.05). Letter d, indicates that the 10 µM group is significantly different from the all other groups except for the vehicle group (p<0.06).
2. The effect of RA on nuclear and cytoplasmic maturation in 
vitro
To examine the effects of RA on the maturation of mouse oocytes, 
Immature COCs from 17-day-old mice were incubated with 0, 10 nM, 
100 nM, 1 µM and 10 µM RA as summarized in Figure 2. As a control 
for the effect of the vehicle solution, COCs were treated with 0.1% 
ethanol alone. The maturation rates of the control and vehicle groups 
were 79.6% and 75.2%, respectively. The rate of maturation to MII was 
high est in the presence of 100 nM RA (91.9%), and maturation rates 
of the 10 nM and 1 µM groups were comparable as 86.9% and 85.4% 
(Figure 3A). 
The oocyte activation rate was also highest in the presence of 100 
nM RA (56%), as compared to control (46.89%) and vehicle (34.91%) 
groups (Figure 3B). Post hoc analysis showed that the vehicle group 
was significantly different from the three conditioned group includ-
ing 10 nM, 100 nM, and 1 µM (p<0.03). The 10 µM group differed sig-
nificantly from all the other groups with the exception of the vehicle 
group (p<0.06).
3. The effect of RA on Irf-1 mRNA and cytokine expression
To determine the effect of RA on Irf-1 mRNA expression, we per-
formed quantitative real-time PCR analysis using cDNA from separat-
ed oocytes and cumulus cells. In oocytes, Irf-1 mRNA expression was 
markedly decreased by 100 nM (Figure 4A), as compared to that of   http://dx.doi.org/10.5653/cerm.2011.38.4.193
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A B
Figure 4. The effect of retinoic acid (RA) on interferon regulatory factor (Irf)-1 mRNA expression in oocytes (A) and cumulus cells (B). Data repre-
sents the means±SE of at least three experiments. (A) Letter a, indicates that 100 nM is significantly different from all other groups except for 
the control group. Letter b, indicates that the 10 µM group is significantly different from the control and 100 nM groups (p<0.05). (B) Letter c, 
indicates that control group is significantly different from all other groups except for the 100 nM group (p<0.05); while letter d, indicates 100 
nM group is significantly different from all other groups except for the control group. 
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control. There were significant differences in mRNA expression levels 
between 100 nM and all the other groups. The mRNA expression lev-
el of the 10 µM group was about twice as much as the control group. 
In cumulus cells, the pattern of expression of Irf-1 mRNA was similar 
to that of oocytes, but the fold changes were much larger than in oo-
cytes (Figure 4B). As shown in Figure 4B, the control group expressed 
the lowest level of mRNA among six groups (p<0.002). Contrast anal-
yses showed there were significant differences in mRNA expression 
level between control group and all the other groups with exception 
of 100 nM group (p<0.02). 
We examined the expression levels of 23 cytokines in culture medi-
um using Bio-Plex system and detected substantial changes in the 
expression of 4 cytokines, such as TNF-α, MIP-1b, eotaxin and IL-12 
(p40) in the presence of RA. The secretion profiles of these four cyto-
kines are summarized in Figure 5. 
In the case of TNF-α, the 100 nM group showed the lowest level 
among six groups with the highest level in 10 µM group. The level of 
TNF-α of 100 nM was significantly less than those of 10 nM and 1 µM 
(p<0.05). There was significant group difference in the MIP-1b level 
(p<0.004). The 10 µM group exhibited the highest level of MIP-1b 
with a significant difference compared to all the other groups. The 
level of eotaxin and IL-12 in the control group was significantly high-
er than those in any other conditioned groups (p<0.001). Results 
clearly showed that all the conditions decrease the level of eotaxin 
and IL-12 in comparison to control group.
4. The effect of RA on apoptosis in CCs
To determine the effect of RA on apoptosis of COCs, we performed 
the TUNEL assay. A representative result, showing red-stained apop-
totic cells, is shown in Figure 6A. The rate of COC apoptosis was low-
est in the presence of 100 nM RA (20.86%), and this was significantly 
lower than that of the control (43%) or vehicle (43.02%) groups. The 
rates of apoptosis increased significantly in the presence of 1 µM and 
10 µM RA (57.33% and 76.17%, respectively, Figure 6B). 
Discussion
In the current study, we demonstrated that 1) RA treatment of im-
mature COCs in vitro has a beneficial effect on increasing oocyte mat-
uration rates; 2) RA may reduce cumulus cell apoptosis through the 
reduction of Irf-1 expression and destructive cytokine secretion from 
oocytes, in particular from cumulus cells; and 3) these changes may 
be favorable for producing high quality oocytes. 
Retinoid, in particular RA, can induce differentiation in a number of 
cells, and plays a role in the regulation of the cell cycle [16]. However, 
while RA can induce or silence the expression of hundreds of genes, 
little is known about the molecular mechanism of action of RA within 
intact tissues [17,18]. In the current study, treatment of immature 
COCs with RA during IVM, especially at 100 nM concentration, impro-
ved both nuclear and cytoplasmic oocyte maturation with lowest 
apoptosis in cumulus cells. 
Ovarian follicular cells are regulated through a variety of mecha-www.eCERM.org
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nisms that involve the action and interactions of endocrine, paracrine 
and autocrine factors. To date, gene expression studies of Rar and Rxr 
family have not focused on ovarian follicular cells, including oocytes. 
In the current study, we investigated the role of RA during spontane-
ous IVM, and characterized the expression patterns of RARs and RXRs 
in ovarian follicular cells. Retinoids function through the RAR and RXR 
families of transcription factors, each of which is comprised of multi-
ple isotypes (α, β, γ). RAR and RXR form heterodimers (RAR-RXR) that 
function in transmitting RA signals [19]. Previous studies have shown 
that Rxrα and Rxrβ are ubiquitously expressed in the mouse embryo 
during development, whereas Rxrγ exhibits a restricted pattern of 
expression during embryogenesis [20]. We found that Rxrα and Rxrβ, 
not Rxrγ, are present in ovarian follicles. The expression of RAR and 
RXR family transcription factors in ovarian follicles suggests that cer-
tain receptor isoforms might function in RA signaling during oocyte 
maturation, fertilization and embryo development. RXRγ, however, 
does not appear to be involved in these processes. 
IRF-1 is a regulator of the cell cycle and apoptosis, and inactivation 
of IRF-1 accelerates the process of cellular transformation. IRF-1 func-
tions as a transcription factor to induce genes involved in strength-
ening immune responses and promoting cancer prevention [21]. 
BRCA1-induced IRF-1 nuclear localization and its transcriptional ac-
tivity activate a multi-component network containing OAS-2 and 
RNase L [22]. TNF-related apoptosis inducing ligand (TRAIL) and oth-
er IRF-1 responsive genes may function in concert to induce apopto-
sis in cancer cells. The tumor suppressor functions of RNase L can also 
amplify the apoptotic signals generated by TRAIL [23]. At a concen-
tration of 10-100 nM, RA significantly reduced the rate of apoptosis 
of cumulus cells. Cumulus cells undergo apoptosis during IVM, and it 
has been proposed that there is a negative correlation between the 
degree of cumulus cell apoptosis during IVM and the developmental 
competence of COCs [24]. 
A complex array of regulatory factors, including hormones, cyto-
kines and growth factors, influence oocyte viability and development 
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potential, either directly or indirectly [25,26]. Cytokines, in particular, 
play an important role in the regulation of ovarian function, gonadal 
steroid secretion, corpus luteum function, embryonic development 
and implantation. To our knowledge, this is the first report of the si-
multaneous measurement of multiple cytokines from a single COC 
culture after treatment with RA during oocyte maturation. Using the 
Bio-Plex system, which is a bead-based ELISA, the levels of 23 cyto-
kines were assessed. A substantial level and regular pattern of secre-
tion was detected for 4 of the 23 cytokines examined, namely TNF-α, 
MIP-1b, eotaxin and IL-12 (p40). 
TNF-α is a 14 kDa pleiotropic cytokine produced by several cell types, 
particularly the macrophage [27]. During oocyte maturation, TNF-α 
compromises oocyte developmental potential and increases blasto-
mere apoptosis, resulting in reduced embryo survival [28]. MIP-1b is 
an 8 kDa member of the CC chemokine family, and is synthesized by 
a variety of cells, including monocytes and activated T- and B-cells 
[29]. TNF-α and MIP-1b levels were decreased by treatment with 100 
nM RA, and this decrease correlated with decreased Irf-1 expression. 
These results suggest a close functional relationship between the 
regulation of Irf-1 expression and the secretion of TNF-α and MIP-1b. 
Eotaxin is an 8.3 kDa protein that also belongs to the CC family of 
chemokines. It acts through CC chemokine receptor 3 (CCR3) on eo-
sinophils [30]. The accumulation of eosinophils within human tissue 
has been correlated with increased eotaxin expression in a number 
of inflammatory conditions, including atopic asthma, nasal polyps 
and ulcerative colitis [30]. IL-12 is a pleiotropic type 1 cytokine that 
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Figure 6. The effect of retinoic acid (RA) treatment on apop-
tosis of cumulus cells. (A) Representative pictures of terminal 
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NEL) assay showing cumulus-oocyte-complexes (COCs) af-
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ed with Hoechst 33342 (blue). (B) The apoptotic rate was cal-
culated as the number of cells with positive TUNEL staining 
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staining (blue). Letters a and b, indicate that the group mean 
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mediates several biological activities in human T-cells and natural 
killer (NK) cells, including the induction of INFγ production and the 
enhancement of cell mediated cytotoxicity [31]. The presence of IL-
12 in follicular fluid is associated with a negative outcome during IVF, 
which could reflect the immaturity of follicles as well as the negative 
effect of IL-12 on folliculogenesis, oocyte maturation and implanta-
tion [32]. Eotaxin and IL-12 (p40) were decreased by all doses of RA 
examined, as compared to control cells, suggesting that RA has some 
positive effect of the induction of oocyte maturation in vitro by inhib-
iting these cytokines.
In the present study, while the dose of 100 nM RA treatment show-
ed consistent results, dose of 10 nM or 1 µM showed incompatible 
fluctuating results fatefully. Therefore even though the maturation 
and activation rate was increased from 10 nM to 1 µM RA treatment 
(Figure 3), we advocate 100 nM treatment for maintain steadiness of 
the culture system. 
In conclusion, RA enhanced the developmental competence of 
mouse oocytes through the suppression of apoptosis in the mouse 
COCs, oocytes as well as cumulus cells, during IVM. We also present-
ed evidence that RA promotes the cytoplasmic maturation and via-
bility of mouse oocytes through the modulation of Irf-1 gene expres-
sion in cumulus cells and oocytes. The production and secretion of 
several cytokines was also modulated by RA during oocyte matura-
tion, and the secretion pattern of TNF-α and MIP-1b strongly suggests 
a functional relationship between these cytokines and RA through 
Irf-1.
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